CLINICAL_TRIALS
trial_result
· 2013-02-12
Clinical Trial Update: Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer [NA]
Summary
Clinical trial update for erlotinib in women undergoing surgery for stage I–III breast cancer has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer | NA | Status: TERMINATED | Results posted: 2013-02-12